VU0410120

inhibits glycine type 1 transporter

Also Known As:

2,4-dichloro-N-((4-(cyclopropylmethyl)-1-(ethylsulfonyl)piperidin-4-yl)methyl)benzamide; M22 benzamide compound

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Autistic Disorder (Autism) 08/03/2015 - "Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autism."